Case Report

Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review

Table 2

KRD-PACE dosing schedule for patient 1 and KRD-PACE dosing schedule for patient 2.

28d cycleKRDPACE

A: Patient 1, KRD-PACE schedule
Dose20 mg/m2 (day 1) then 56 mg/m2 thereafter25 mg40 mg10 mg/m210 mg/m2400 mg/m240 mg/m2
ScheduleDays 1, 2, 8, 9, 15, 16Days 1–21Days 1–4Days 1–4Days 1–4Days 1–4Days 1–4

B: Patient 2, KRD-PACE schedule
Dose20 mg/m2 (day 1) then 27 mg/m215 mg40 mg10 mg/m210 mg/m2400 mg/m240 mg/m2
ScheduleDays 1,2Days 1–21Days 1–4Days 1–4Days 1–4Days 1–4Days 1–4